Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $4,349 | 201 | 46.7% |
| Consulting Fee | $3,756 | 3 | 40.3% |
| Education | $1,214 | 21 | 13.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| GE HEALTHCARE | $3,756 | 3 | $0 (2019) |
| Janssen Biotech, Inc. | $840.89 | 20 | $0 (2024) |
| Astellas Pharma US Inc | $635.86 | 17 | $0 (2024) |
| PFIZER INC. | $478.62 | 19 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $310.99 | 15 | $0 (2023) |
| Lexicon Pharmaceuticals, Inc. | $282.97 | 4 | $0 (2017) |
| Lilly USA, LLC | $264.18 | 14 | $0 (2020) |
| Genentech USA, Inc. | $231.60 | 17 | $0 (2019) |
| Pharmacyclics LLC, an AbbVie Company | $218.31 | 6 | $0 (2022) |
| Novartis Pharmaceuticals Corporation | $187.77 | 10 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $665.10 | 23 | Astellas Pharma US Inc ($250.39) |
| 2023 | $555.89 | 16 | Astellas Pharma US Inc ($249.02) |
| 2022 | $436.01 | 15 | Janssen Biotech, Inc. ($145.12) |
| 2021 | $329.88 | 7 | Janssen Biotech, Inc. ($184.00) |
| 2020 | $396.32 | 16 | Janssen Biotech, Inc. ($149.91) |
| 2019 | $4,414 | 34 | GE HEALTHCARE ($3,756) |
| 2018 | $1,122 | 50 | Pharmacyclics LLC, An AbbVie Company ($120.47) |
| 2017 | $1,400 | 64 | Lexicon Pharmaceuticals, Inc. ($282.97) |
All Payment Transactions
225 individual payment records from CMS Open Payments — Page 1 of 9
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | PFIZER INC. | XTANDI (Drug), ORGOVYX, TALZENNA | Food and Beverage | In-kind items and services | $28.81 | General |
| Category: ONCOLOGY | ||||||
| 12/05/2024 | Novocure Inc. | Optune Lua (NovoTTF-200T) (Device) | Food and Beverage | Cash or cash equivalent | $23.48 | General |
| Category: Oncology | ||||||
| 11/20/2024 | Sumitomo Pharma America, Inc. | ORGOVYX (Drug) | Food and Beverage | In-kind items and services | $20.17 | General |
| Category: HORMONE THERAPY | ||||||
| 11/11/2024 | Astellas Pharma US Inc | — | Education | In-kind items and services | $99.95 | General |
| 10/29/2024 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, ABRYSVO | Food and Beverage | In-kind items and services | $31.48 | General |
| Category: VACCINES | ||||||
| 10/29/2024 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, ABRYSVO | Food and Beverage | In-kind items and services | $13.76 | General |
| Category: VACCINES | ||||||
| 09/23/2024 | Astellas Pharma US Inc | — | Education | In-kind items and services | $99.99 | General |
| 08/12/2024 | SANOFI PASTEUR INC. | FLUBLOK QUADRIVALENT NORTHERN HEMISPHERE (Biological), FLUZONE HIGH-DOSE | Food and Beverage | In-kind items and services | $27.39 | General |
| Category: Vaccines | ||||||
| 07/30/2024 | Janssen Biotech, Inc. | DARZALEX (Biological), TECVAYLI, TALVEY | Food and Beverage | In-kind items and services | $20.36 | General |
| Category: Oncology | ||||||
| 07/18/2024 | Sumitomo Pharma America, Inc. | ORGOVYX (Drug) | Food and Beverage | In-kind items and services | $23.39 | General |
| Category: HORMONE THERAPY | ||||||
| 07/09/2024 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, ABRYSVO | Food and Beverage | In-kind items and services | $23.39 | General |
| Category: VACCINES | ||||||
| 05/23/2024 | AstraZeneca Pharmaceuticals LP | TAGRISSO (Drug) | Food and Beverage | In-kind items and services | $16.08 | General |
| Category: Oncology | ||||||
| 05/13/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $22.86 | General |
| Category: Oncology | ||||||
| 05/09/2024 | ARRAY BIOPHARMA INC | XALKORI (Drug), LORBRENA, BRAFTOVI | Food and Beverage | In-kind items and services | $23.39 | General |
| Category: ONCOLOGY | ||||||
| 04/02/2024 | Janssen Biotech, Inc. | DARZALEX (Biological), TECVAYLI, TALVEY | Food and Beverage | In-kind items and services | $22.13 | General |
| Category: Oncology | ||||||
| 03/27/2024 | SANOFI PASTEUR INC. | FLUBLOK QUADRIVALENT NORTHERN HEMISPHERE (Biological), FLUZONE HIGH-DOSE | Food and Beverage | In-kind items and services | $22.37 | General |
| Category: Vaccines | ||||||
| 03/19/2024 | Astellas Pharma US Inc | Xtandi (Drug) | Food and Beverage | In-kind items and services | $18.55 | General |
| Category: Oncology | ||||||
| 03/12/2024 | Astellas Pharma US Inc | Xtandi (Drug) | Food and Beverage | In-kind items and services | $17.00 | General |
| Category: Oncology | ||||||
| 03/12/2024 | Astellas Pharma US Inc | Xtandi (Drug) | Food and Beverage | In-kind items and services | $14.90 | General |
| Category: Oncology | ||||||
| 03/06/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $23.53 | General |
| Category: Oncology | ||||||
| 02/21/2024 | Sumitomo Pharma America, Inc. | ORGOVYX (Drug) | Food and Beverage | In-kind items and services | $24.36 | General |
| Category: HORMONE THERAPY | ||||||
| 01/17/2024 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, ABRYSVO | Food and Beverage | In-kind items and services | $25.93 | General |
| Category: VACCINES | ||||||
| 01/11/2024 | ARRAY BIOPHARMA INC | XALKORI (Drug), LORBRENA, BRAFTOVI | Food and Beverage | In-kind items and services | $21.83 | General |
| Category: ONCOLOGY | ||||||
| 12/06/2023 | Astellas Pharma US Inc | Xtandi (Drug) | Food and Beverage | In-kind items and services | $20.84 | General |
| Category: Oncology | ||||||
| 11/28/2023 | Sumitomo Pharma America, Inc. | ORGOVYX (Drug) | Food and Beverage | In-kind items and services | $19.88 | General |
| Category: HORMONE THERAPY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 25 | 2,519 | 3,603 | $220,759 | $155,012 |
| 2022 | 22 | 2,369 | 3,476 | $195,317 | $139,133 |
| 2021 | 24 | 2,233 | 3,440 | $179,313 | $140,933 |
| 2020 | 26 | 2,218 | 3,171 | $163,618 | $126,407 |
All Medicare Procedures & Services
97 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 152 | 283 | $43,559 | $31,171 | 71.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 153 | 321 | $35,379 | $24,234 | 68.5% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 159 | 159 | $31,005 | $24,017 | 77.5% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 18 | 93 | $14,136 | $10,231 | 72.4% |
| 99496 | Transitional care management services for problem of high complexity | Office | 2023 | 30 | 36 | $14,760 | $9,341 | 63.3% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 36 | 36 | $11,772 | $7,247 | 61.6% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 95 | 95 | $9,500 | $6,761 | 71.2% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 36 | 49 | $8,602 | $6,592 | 76.6% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 128 | 129 | $4,515 | $4,425 | 98.0% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 21 | 27 | $7,911 | $4,329 | 54.7% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2023 | 238 | 503 | $5,732 | $3,813 | 66.5% |
| G0328 | Colorectal cancer screening; fecal occult blood test, immunoassay, 1-3 simultaneous | Office | 2023 | 182 | 182 | $4,914 | $3,220 | 65.5% |
| G0444 | Annual depression screening, 5 to 15 minutes | Office | 2023 | 134 | 134 | $3,618 | $2,931 | 81.0% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 203 | 225 | $4,795 | $2,851 | 59.5% |
| G0402 | Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Office | 2023 | 12 | 12 | $3,600 | $2,325 | 64.6% |
| 80061 | Blood test, lipids (cholesterol and triglycerides) | Office | 2023 | 168 | 170 | $3,266 | $2,230 | 68.3% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2023 | 14 | 20 | $3,120 | $2,131 | 68.3% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 254 | 630 | $2,058 | $1,895 | 92.1% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2023 | 18 | 21 | $2,835 | $1,785 | 63.0% |
| 99441 | Telephone medical discussion with physician, 5-10 minutes | Office | 2023 | 26 | 28 | $1,549 | $1,185 | 76.5% |
| 82570 | Creatinine level to test for kidney function or muscle injury | Office | 2023 | 182 | 183 | $1,340 | $929.64 | 69.4% |
| 90686 | Influenza vaccine, quadrivalent, preservative free, 0.5 ml dosage | Office | 2023 | 34 | 35 | $1,925 | $742.17 | 38.6% |
| 81003 | Automated urinalysis test | Office | 2023 | 185 | 187 | $602.76 | $411.40 | 68.3% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Facility | 2023 | 12 | 15 | $146.40 | $111.15 | 75.9% |
| 81002 | Urinalysis, manual test | Office | 2023 | 29 | 30 | $119.40 | $102.30 | 85.7% |
About Dr. Mitchell Berger, MD
Dr. Mitchell Berger, MD is a Internal Medicine healthcare provider based in New Hyde Park, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/15/2006. The National Provider Identifier (NPI) number assigned to this provider is 1053362970.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Mitchell Berger, MD has received a total of $9,319 in payments from pharmaceutical and medical device companies, with $665.10 received in 2024. These payments were reported across 225 transactions from 49 companies. The most common payment nature is "Food and Beverage" ($4,349).
As a Medicare-enrolled provider, Berger has provided services to 9,339 Medicare beneficiaries, totaling 13,690 services with total Medicare billing of $561,486. Data is available for 4 years (2020–2023), covering 97 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Other Specialties Medical Oncology
- Location New Hyde Park, NY
- Active Since 05/15/2006
- Last Updated 12/30/2011
- Taxonomy Code 207R00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1053362970
Products in Payments
- XTANDI (Drug) $451.70
- ERLEADA (Drug) $435.52
- Xermelo (Drug) $282.97
- DARZALEX (Biological) $226.74
- OPDIVO (Biological) $226.52
- ORGOVYX (Drug) $224.78
- CYRAMZA (Drug) $169.82
- Imbruvica (Drug) $163.28
- IMBRUVICA (Drug) $150.03
- Zevalin (Drug) $143.85
- Xtandi (Drug) $114.53
- Revlimid (Drug) $113.26
- TECENTRIQ (Biological) $105.62
- PREVNAR 20 (Biological) $94.56
- JADENU (Drug) $94.32
- VENCLEXTA (Biological) $82.67
- INJECTAFER (Drug) $80.99
- Erleada (Drug) $78.89
- XALKORI (Drug) $73.49
- TAGRISSO (Drug) $71.36
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in New Hyde Park
Dr. Michael Levine, Md, MD
Internal Medicine — Payments: $394,059
Nikhil Sharma, M.d, M.D
Internal Medicine — Payments: $89,735
Nagashree Seetharamu, Md, MD
Internal Medicine — Payments: $65,767
Dr. Abhinav Agrawal, M.d, M.D
Internal Medicine — Payments: $49,576
Dr. Thomas Mathew, Md, MD
Internal Medicine — Payments: $47,542
Dr. Kennedy Omonuwa, M.d, M.D
Internal Medicine — Payments: $45,556